• Nenhum resultado encontrado

[PDF] Top 20 Response monitoring in de novo patients with Parkinson's disease.

Has 10000 "Response monitoring in de novo patients with Parkinson's disease." found on our website. Below are the top 20 most common "Response monitoring in de novo patients with Parkinson's disease.".

Response monitoring in de novo patients with Parkinson's disease.

Response monitoring in de novo patients with Parkinson's disease.

... Ne in the patient group is in line with the reinforcement-learning hypothesis ...[3]. In light of this, it is interesting that phasic DA signals in medial frontal areas, as they are ... See full document

5

Tratamento com fator neurotrófico derivado da linhagem das células gliais em pacientes com doença de parkinson / Treatment with glial cell line-derived neurotrophic factor in patients with parkinson disease

Tratamento com fator neurotrófico derivado da linhagem das células gliais em pacientes com doença de parkinson / Treatment with glial cell line-derived neurotrophic factor in patients with parkinson disease

... Entre os estudos clínicos que indicaram resultados positivos na administração de GDNF em pacientes com DP utilizando a administração intraputaminal, está o estudo de Gill et al. (2003), que aplicou GDNF diretamente no ... See full document

15

Depression increases in patients with Parkinson?s disease according to the increasing severity of the cognitive impairment

Depression increases in patients with Parkinson?s disease according to the increasing severity of the cognitive impairment

... older with cognitive impairment living in defined catchment ...PD with decreased scores in the cognitive test (Adjusted OR from ...increases with the severity of the cognitive ... See full document

4

Arq. NeuroPsiquiatr.  vol.75 número4

Arq. NeuroPsiquiatr. vol.75 número4

... symptoms in patients with Parkinson’s disease ...decline in verbal luency ...luency in Brazilian PD ...Parkinson’s Disease Rating Scale - Part III and for phonemic luency ... See full document

5

Braz. J. Phys. Ther.  vol.11 número2 en a07v11n2

Braz. J. Phys. Ther. vol.11 número2 en a07v11n2

... performance in Parkinson’s disease ...10 patients with a diagnosis of Parkinson’s disease. In both groups, the ages were between 47 and 75 years and the individuals were paired ... See full document

5

Unraveling the neuroprotective role of TUDCA in Parkinson´s disease

Unraveling the neuroprotective role of TUDCA in Parkinson´s disease

... neuroprotective in Huntington’s disease models, as it prevented 3-nitropropionic acid (a mitochondrial inhibitor of Complex II, which induces striatal lesions similar to those observed in ... See full document

69

Metamemory monitoring in Alzheimer’s disease

Metamemory monitoring in Alzheimer’s disease

... judgment response was either a yes or ...function in explaining FOK inaccuracy. Correa et al. 19 evaluated metamemory in PwAD, MCI and HE by ... See full document

16

Parkinson s disease and dopamine transporter neuroimaging: a critical review

Parkinson s disease and dopamine transporter neuroimaging: a critical review

... variability in uptake values suggests that factors other than nigrostriatal degenera- tion may contribute towards disease ...correlation with bradykinesia but not with tremor, thus suggesting ... See full document

8

Diagnostic validity of biomarkers in Parkinson’s Disease: systematic review and meta-analysis

Diagnostic validity of biomarkers in Parkinson’s Disease: systematic review and meta-analysis

... disorders in its profile is useful for the detection and diagnosis of various ...changes in serum antibody expression ...that, with only 10 antibody biomarkers, the serum samples from the PD ... See full document

10

Arq. NeuroPsiquiatr.  vol.73 número3

Arq. NeuroPsiquiatr. vol.73 número3

... disorders in Parkinson’s disease are very ...120 patients with Parkinson’s disease were ...All patients underwent a standardized overnight, single night ...(78.3%) ... See full document

5

Factors associated with depression in patients with Parkinson’s disease

Factors associated with depression in patients with Parkinson’s disease

... disorders in sleep, and rapid disease progression ...associated with patients suffering from depression included having a HY stage ...of disease; as well as both phar- macological ... See full document

7

Arq. NeuroPsiquiatr.  vol.74 número4

Arq. NeuroPsiquiatr. vol.74 número4

... described in different neurological ...ISA in patients with movement ...Fifteen patients with different forms of movement disorders (Parkinson’s disease, Huntington’s ... See full document

4

Fluency in Parkinson's disease: disease duration, cognitive status and age

Fluency in Parkinson's disease: disease duration, cognitive status and age

... present in the speech of any speaker in the absence of fluency changes characterizing ...phenomena in the speech of the PD ...associated with increased hesitations and pauses ... See full document

7

Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.

Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.

... neuroinflammation in PD patients using [ 11 C](R) PK11195 ...binding in the nigro-striatal regions [8], others did not support these observa- tions ...binding in the nigro-striatal regions and ... See full document

10

Nullity of GSTT1/GSTM1 related to pesticides is associatedwith Parkinson's disease

Nullity of GSTT1/GSTM1 related to pesticides is associatedwith Parkinson's disease

... factors in neu- rodegenerative diseases. horough studies should be con- ducted in various groups of population, in order to charac- terize smaller speciic groups of PD susceptible individuals ( for ... See full document

6

Gene Expression Differences in Peripheral Blood of Parkinson ’s Disease Patients with Distinct Progression Profiles

Gene Expression Differences in Peripheral Blood of Parkinson ’s Disease Patients with Distinct Progression Profiles

... separate patients into two distinct groups with “Slow” or “Fast” progression, depending on the absence or presence of postural instability, ...associated with poorer quality of life [5]. It is ... See full document

19

Clinical Characterization of Parkinson s Disease Patients Followed at CHCB Comparison with a control group

Clinical Characterization of Parkinson s Disease Patients Followed at CHCB Comparison with a control group

... IL-12p70 in PD patients and HC and to compare the cytokine pattern between those two ...analyte in less time and using fewer sample dilutions, because of the broad dynamic range of fluorescent ... See full document

70

Intra-Rater, Inter-Rater and Test-Retest Reliability of an Instrumented Timed Up and Go (iTUG) Test in Patients with Parkinson's Disease.

Intra-Rater, Inter-Rater and Test-Retest Reliability of an Instrumented Timed Up and Go (iTUG) Test in Patients with Parkinson's Disease.

... measured with a small and light (87×45×14 mm, 74 grams) inertial sensor measurement system (DynaPort Hybrid, McRoberts, The Hague, The Netherlands), which was inserted in an elastic belt and positioned on ... See full document

11

Prediction of Coronary Risk by SYNTAX and Derived Scores Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery

Prediction of Coronary Risk by SYNTAX and Derived Scores Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery

... SS with the modified ACEF (Age, Creatinine clearance and Ejection Fraction) ...outcomes with comparable accuracy as that of EuroSCORE in patients undergoing CABG ...values. In the study ... See full document

12

THE CYTOKINE IP-10 IN CHRONIC HBV AND HCV INFECTION

THE CYTOKINE IP-10 IN CHRONIC HBV AND HCV INFECTION

... All patients with chronic HBV infection were adults, has apositive test for HBsAg, an HBV DNA detectalbe, and 2 serum alanine aminotransferase values above the upper limit of normal within 6 months of ... See full document

6

Show all 10000 documents...